MedPath

Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia

Not Applicable
Completed
Conditions
Fibromyalgia
Interventions
Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Registration Number
NCT03133455
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.

The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
107
Inclusion Criteria
  • FM Criteria of the American College of Rheumatology ACR 1990.
  • Major Patients
  • free and informed consent signed
  • stable treatment for at least one month
  • Native French speaker
  • Patient covered by health insurance.
Exclusion Criteria
  • Patient deprived of liberty or protected major (under guardianship or curatorship)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patient with FibromyalgiaEvaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.-
Primary Outcome Measures
NameTimeMethod
Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire1 hour

Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens Picardie

🇫🇷

Amiens, Picardie, France

© Copyright 2025. All Rights Reserved by MedPath